VYEPTI conc perf 100 mg/ml flac 1 ml
7680679950016
CH-67995
N02CD05
02.05.1.
Reimbursement limitations:
VYEPTI.01
Le traitement nécessite une garantie de prise en charge des frais par l’assureur maladie, après …
1 / 3
google
Details
- Product number
- 6799501
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Durchstechflasche(n)
- Composition
- eptinezumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, sorbitolum 40.5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Vyepti 100 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
40.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1257.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
Lundbeck (Schweiz) AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 67995
- Drug name
- Vyepti, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- N02CD05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/10/2021
- Authorization expiration date
- 10/10/2026
- IT number
- 02.05.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VYEPTI conc perf 100 mg/ml flac 1 ml
- Description (DE)
- VYEPTI Inf Konz 100 mg/ml Durchstf 1 ml
- Market launch
- 11/10/2021
- Narcotic (BTM)
- No